Innovatus Life Sciences Acquisition Corp.
| General Information | |
| Business: | This life sciences-focused blank check company, or SPAC, withdrew its IPO plans in an SEC filing dated July 20, 2022. This IPO was planned as a stock-only deal – no warrants. |
| Industry: | BLANK CHECK |
| Employees: | 0 |
| Founded: | 2021 |
| Contact Information | |
| Address | 777 Third Avenue, 25th Floor New York, New York 10017 |
| Phone Number | (212) 698-4580 |
| Web Address | |
| View Prospectus: | Innovatus Life Sciences Acquisition Corp. |
| Financial Information | |
| Market Cap | $212.0mil |
| Revenues | $0 mil (last 12 months) |
| Net Income | $0 mil (last 12 months) |
| IPO Profile | |
| Symbol | ILAC |
| Exchange | |
| Shares (millions): | 17.5 |
| Price range | $10.00 - $10.00 |
| Est. $ Volume | $175.0 mil |
| Manager / Joint Managers | UBS Investment Bank |
| CO-Managers | |
| Expected To Trade: | |
| Status: | Withdrawn |
| Quiet Period Expiration Date: | Available only to Subscribers |
| Lock-Up Period Expiration Date: | Available only to Subscribers |
| SCOOP Rating | Available only to Subscribers |
| Rating Change | Available only to Subscribers |